Treatment considerations for patients with pemphigus during the COVID-19 pandemic
Hadir Shakshouk, Maryam Daneshpazhooh, Dédée F. Murrell, Julia S. Lehman
Topics & Concepts
MedicinePemphigusRituximabImmunosuppressionRetrospective cohort studyPandemicPopulationPrednisoneInternal medicineImmunologyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)AntibodyEnvironmental healthAutoimmune Bullous Skin DiseasesPlatelet Disorders and TreatmentsUrticaria and Related Conditions